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ABSTRACT
Cancer is, in essence, a stem cell disease. The main biological cause of cancer 
is that stem cells acquire DNA alterations during cell division. The more stem cell 
divisions a tissue accumulates over a lifetime, the higher is the risk of cancer in that 
tissue. This explains why cancer is diagnosed millions of times more often in some 
tissues than in others, and why cancer incidence increases so dramatically with age. It 
may also explain why taking a daily low-dose aspirin for several years reduces the risk 
of developing and dying from cancer. Since aspirin use reduces PGE2 levels and PGE2 
fuels stem cell proliferation, aspirin may prevent cancer by restricting the division 
rates of stem cells. The stem cell division model of cancer may also explain why 
regular consumption of very hot foods and beverages increases the risk of developing 
esophageal cancer. Given that tissue injury activates stem cell division for repair, the 
thermal injury associated with this dietary habit will increase esophageal cancer risk 
by inducing the accumulation of stem cell divisions in the esophagus. Using these 
two examples, here I propose that controlling the division rates of stem cells is an 
essential approach to preventing cancer.
INTRODUCTION
Recent evidence indicates that we have cancer 
because our stem cells divide [1-3]. The division of 
stem cells is necessary to form, maintain and repair our 
tissues. But when they divide, their DNA gets damaged 
and our risk of cancer increases. Dividing cells are 
exposed, for example, to random mutations arising 
during DNA replication and to stochastic errors in the 
distribution of chromosomes between the daughter cells. 
Dividing cells are also exposed to a variety of damages 
caused by endogenous and environmental carcinogens. 
Importantly, stem cells represent the only cell population 
that can accumulate DNA damage during our whole life; 
they are the only tissue cells that can self-renew (copy 
themselves) and keep our DNA from the beginning of life 
until death. As we age, our tissues accumulate stem cell 
divisions, their stem cells accumulate DNA damage, and 
we accumulate cancer risk [1, 3]. This explains why most 
cancers are diagnosed in aged people [4].
Tomasetti and Vogelstein [2] recently found a highly 
positive correlation (Spearman’s rho = 0.81; P < 3.5 × 
10−8) between the number of normal stem cell divisions 
in a tissue and the risk of cancer in that tissue. The 
correlation applied to 31 cancer types and extended across 
five orders of magnitude [2]. This correlation means that 
if the total number of stem cell divisions in a tissue is 1, 
the risk of being diagnosed with cancer in that tissue is 
approximately 1X. If the number of stem cell divisions 
is 100, the risk is 100X. And if the total number of stem 
cell divisions in a tissue is 100,000, the risk of cancer in 
that tissue is approximately 100,000X [3]. In other words, 
the more stem cell divisions a tissue accumulates over a 
lifetime, the higher is the risk of developing cancer in that 
tissue. This implies that restricting the number of stem cell 
divisions will reduce the cancer risk, whereas promoting 
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the division of stem cells will increase the cancer risk.
Here I discuss that aspirin use prevents cancer by 
restricting the division rates of stem cells, and that regular 
consumption of very hot beverages and foods raises the 
risk of esophageal cancer by increasing the number of 
stem cell divisions in the esophagus. Then, I propose 
that controlling the division rates of stem cells may be an 
essential approach to preventing cancer.
Understanding why aspirin use reduces the risk of 
developing and dying from cancer
Taking a daily low-dose aspirin (75-100 mg) for 
several years reduces the risk of developing and dying 
from cancer [5-10]. A recent analysis of multiple clinical 
trials, cohort studies, and case-control studies indicates 
that aspirin use reduces cancer incidence by approximately 
35% in colorectal cancer, 30% in esophageal and gastric 
cancers, 10% in breast and prostate cancers, and 5% in 
lung cancer. Aspirin use also reduces cancer mortality 
by approximately 50% in esophageal cancer, 40% in 
colorectal cancer, 35% in gastric cancer, 15% in lung and 
prostate cancers, and 5% in breast cancer [8]. In addition, 
aspirin reduces cancer mortality in patients previously 
diagnosed with specific tumors [11, 12]; this suggests that 
aspirin can prevent the development of established tumors 
in addition to reducing their occurrence.
Aspirin, a nonsteroidal anti-inflammatory drug 
(NSAID), exerts its known pharmacological properties 
through inhibition of constitutive (COX-1) and inducible 
(COX-2) cyclooxygenases. Inhibition of COX activity 
decreases the formation of prostanoids (e.g., PGE2 and 
TXA2) that promote inflammation, pain, fever, and 
platelet aggregation. Unlike other NSAIDs, aspirin 
causes an irreversible inhibition of the enzyme COX-1. 
The pharmacokinetic profile of aspirin after a low-dose 
administration (high concentrations in portal circulation 
followed by low concentrations in the general circulation) 
suggests that the activity of low-dose aspirin is mediated 
by irreversible inhibition of COX-1 activity in platelets 
(which are exposed to high concentrations of aspirin in 
the portal circulation). This in turn suggests that the 
antiplatelet action of aspirin may mediate its anticancer 
effects [10, 13]. However, aspirin-induced COX-1 
inhibition in platelets lasts several days (platelets live 
several days and cannot synthesize new enzymes because 
they have no nucleus), and alternate-day aspirin does not 
result in considerable reductions in cancer risk [14, 15]. 
This suggests that the antiplatelet activity of aspirin cannot 
fully explain its anticancer effects. Low-dose aspirin may 
reduce the activity of COX-2 by inhibiting its synthesis 
rather than by direct inhibition of the enzyme. Aspirin and 
its stable metabolite salycilate can inhibit COX-2 gene 
transcription at lower concentrations (0.1 µM) [16] than 
those reached by both compounds in plasma (around 10 
µM) after oral administration of low-dose aspirin [17]. 
This may explain why healthy volunteers taking 81 mg of 
aspirin for two weeks had a 45% reduction of PGE2 levels 
in urine samples [10].
The mechanism by which aspirin prevents cancer 
becomes obscure beyond COX inhibition [17, 18], 
probably because the main mechanism involved in cancer 
development has remained obscure until now. Tomasetti 
and Vogelstein [2] recently found a striking correlation 
between the number of normal stem cell divisions in a 
tissue and the risk of cancer in that tissue; this strongly 
suggests that the main biological cause of cancer is that 
stem cells acquire DNA damage during cell division. 
When normal stem cells accumulate sufficient damage, 
they become cancer stem cells (CSCs), which play a key 
role in tumor formation. Cell malignant transformation and 
tumor growth may therefore be prevented by restricting 
the proliferative activity of normal stem cells and CSCs 
[1, 3].
Prostaglandin E2 (PGE2) is known to activate 
normal stem cell proliferation to promote tissue 
regeneration [19, 20]. Enhanced PGE2 production is 
actually a universal response to tissue injury [19]. Through 
its interaction with Wnt, PGE2 plays a key role in stem 
cell self-renewal and tissue regeneration [19]. Recent 
evidence suggests that PGE2 may also activate CSC 
proliferation to promote tumor growth [21]. Following 
chemotherapy, an increase in this prostaglandin induced 
tumor repopulation by stimulating the division of CSCs; 
this effect was abrogated by a PGE2-neutralizing antibody 
and by the COX-2 inhibitor celecoxib [21].
By inhibiting COX-mediated PGE2 production, 
aspirin may restrict the proliferation of normal stem cells 
and CSCs. In other words, aspirin use probably lowers 
cancer risk because it prevents normal stem cells from 
becoming malignant. If they do, aspirin restricts their 
division rates and limits their tumor formation capacity.
Understanding why regular consumption of very 
hot beverages and foods is an important risk 
factor for esophageal cancer
Globally, esophageal cancer is the ninth most 
common malignancy and the sixth most common cause 
of cancer-related death [22]. Smoking and heavy alcohol 
consumption are considered major risk factors for 
esophageal cancer [23, 24]. These risks factors, however, 
cannot explain the striking variations in esophageal cancer 
incidence among countries. For example, while esophageal 
cancer is the 23rd most common cancer in Greece and the 
19th in Russia, it ranks second in Kenya and fourth in Iran 
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[22]. Tobacco and alcohol use in Greece and Russia is 
however much more common than in Kenya and Iran [25] 
(Table 1). These data indicate that esophageal cancer is 
highly influenced by other risk factors. Identifying these 
factors is important for the development of cancer control 
strategies.
Accumulating epidemiological evidence supports 
an association between regular consumption of high-
temperature foods and drinks and an increased risk of 
esophageal cancer [26-28]. For example, most inhabitants 
of Golestan province, Iran, drink tea at temperatures higher 
than 60°C and in quantities greater than one liter per day 
[26]. A case-control study in this population showed 
that drinking hot tea and very hot tea was respectively 
associated with 2.07-fold and 8.16-fold increases in 
the risk of esophageal cancer compared with drinking 
lukewarm or warm tea [26]. A case-control study in the 
Rift Valley, Kenya, also found that drinking hot beverages 
was associated with a 12.78-fold increase in the risk of 
esophageal cancer [29]. Tobacco and alcohol use in this 
population was associated with 2.51-fold and 2.64-fold 
increases in the risk of this malignancy [29].
Despite this epidemiological evidence, regular 
consumption of high-temperature foods and drinks is not 
considered to be an important risk factor for esophageal 
cancer. This risk is mentioned in some cancer prevention 
guidelines and specialized web pages; however, it is 
not indicated that this dietary habit should be avoided, 
probably because the level of evidence is not considered 
adequate. In other guidelines and specialized websites, 
the cancer risk associated with this habit is not even 
mentioned. A possible reason is that the prevailing model 
of carcinogenesis states that cancer is caused by genetic 
mutations, and thermal tissue injury is not regarded as a 
significant source of mutations. But recent data indicate 
that tissue injury may be an important source of DNA 
damage to the cells that give rise to cancer [1].
When we drink or eat something hot enough to 
cause severe damage to the cells lining the esophagus, the 
stem cells of this tissue [30] have to divide to produce 
new cells to repair the damage. But when they divide, their 
DNA becomes exposed to unavoidable errors associated 
with cell division, and also becomes more vulnerable to 
the genotoxic activity of endogenous carcinogens (e.g., 
reactive oxygen and nitrogen species produced during 
inflammation) and exogenous carcinogens (e.g., tobacco 
and dietary carcinogens). The more times we ingest very 
hot foods and drinks, the more stem cell divisions will 
take place in the esophagus, the more DNA alterations will 
acquire the stem cells of this tissue, and the higher will be 
the risk of developing esophageal cancer.
In many countries, consuming very hot foods and 
drinks is probably less common than smoking or drinking 
alcohol. This means that tobacco and alcohol use may 
cause more cases of esophageal cancer in these countries 
and globally. However, the individual risk associated with 
this dietary habit may be comparable or even higher than 
that associated with tobacco and alcohol use. In other 
words, if an individual ingests scalding-hot beverages 
and foods regularly, his or her chance of developing 
esophageal cancer might be even higher than the risk of a 
smoker or a heavy alcohol drinker. The high incidence of 
esophageal cancer in countries where drinking scalding-
hot tea is a common practice (e.g., Iran and Kenya) 
supports this possibility. Unfortunately, most people are 
unaware of the risk of cancer associated with this dietary 
habit.
There is sufficient epidemiological and mechanistic 
evidence to support that this dietary habit is an important 
risk factor for esophageal cancer. First, the incidence of 
esophageal cancer is generally very high in some countries 
where this dietary practice is common. Second, numerous 
case-control studies in different parts of the world show 
an increased risk of esophageal cancer in people with this 
habit [27]. Third, recent evidence indicates that the main 
biological cause of cancer is the accumulation of stem 
cell divisions in our tissues, and regular thermal injury to 
the esophagus will lead to the accumulation of stem cell 
divisions in this tissue.
Recognizing that regular consumption of high-
temperature beverages and foods is an important risk 
factor for esophageal cancer is an essential step to take 
preventive measures. Taking preventive measures is 
crucial, because therapy is not usually curative even 
Table 1: Differences in esophageal cancer incidence and mortality among some countries 
are not explained by cigarette and alcohol use.
Country Incidence ranking1 Mortality ranking1 Cigarette use2 Alcohol use3
Greece 23 20 2,717 10.3
Russia 19 13 2,659 15.1
Kenya 2 1 415 4.3
Iran 4 2 925 1.0
1 Ranking of esophageal cancer with respect to other cancers in the country [22].
2 Mean cigarette consumption per capita in 2012 [25].
3 Mean alcohol consumption per capita (in liters of pure alcohol; 15+ years population) in 2010 (WHO Global status 
report on alcohol and health 2014).
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when this cancer is detected early; the five-year relative 
survival rates for esophageal cancer are about 20% [31]. 
In addition, since consuming very hot foods and drinks is 
avoidable and probably less addictive than smoking and 
drinking alcohol, these measures are likely to be effective. 
In individuals and populations with this dietary habit, 
simple measures like waiting for the soup to cool down 
or adding some cold water or milk to a boiling cup of tea 
may prevent more esophageal cancer deaths than therapy, 
and at a lower cost. This information should reach health 
policy-makers. It should reach people.
Controlling the division rates of stem cells is an 
important strategy to prevent cancer
If the accumulation of DNA alterations in dividing 
stem cells is the major biological cause of cancer, 
controlling the division rates of stem cells may be an 
essential approach to preventing the disease. However, 
since stem cells have to divide to maintain and repair our 
tissues, one might think that restricting their division rates 
will compromise these important biological functions. One 
should be reminded that restricting an important biological 
function does not necessarily have to be harmful. 
For example, cholesterol plays an important role in 
maintaining the fluidity of cell membranes. Blood pressure 
is also necessary to ensure an adequate delivery of oxygen 
and nutrients to cells. However, restricting cholesterol 
and blood pressure levels does not necessarily have to be 
harmful. Avoiding hypercholesterolemia and hypertension 
through primary prevention (e.g., by limiting cholesterol 
and salt intake) and through secondary prevention (e.g., by 
using statins and ACE inhibitors) is actually an essential 
approach to preventing cardiovascular disease. Avoiding 
an overproliferation of stem cells may also be an essential 
approach to preventing cancer. 
Primary cancer prevention can be achieved by 
identifying and controlling external factors that promote 
the division of stem cells. This research perspective shows 
that tissue injury is one of these factors. This can explain 
why the tissue injury associated with the consumption 
of very hot beverages and foods increases the risk of 
esophageal cancer [26, 27]. It may also explain why 
other types of tissue injury increase the risk of cancer 
[32-39]. For example, a case-control study found that 
women with breast carcinoma were more likely to report 
physical trauma to the breast in the previous five years 
than were women without breast carcinoma (OR = 3.3; 
95% CI = 1.3-10.8; P < 0.0001) [39]. Another case-control 
study found that head trauma was associated with an 
increased risk of meningioma (OR = 1.83; 95% CI = 1.28-
2.62), especially head traumas occurring 10 to 19 years 
before diagnosis (OR = 4.33; 95% CI = 2.06-9.10) [38]. 
Epidemiological and mechanistic evidence indicates that 
tissue injury increases cancer risk; some types of tissue 
injury can be avoided.
Tissue injury activates signals, such as PGE2, that 
stimulate the division of stem cells to promote tissue 
regeneration. A recent article showed that inhibition of the 
prostaglandin-degrading enzyme 15-PGDH potentiates 
tissue regeneration by increasing tissue levels of PGE2 
[20]. The authors discussed that 15-PGDH inhibition may 
be a valuable therapeutic strategy for tissue regeneration in 
diverse clinical contexts [20]. In my opinion, potentiating 
tissue regeneration may lead to an overproliferation of 
stem cells and may increase the risk of cancer. The benefit-
risk profile of this therapeutic strategy should be carefully 
considered in each situation.
Introducing stem cells into our tissues for 
regenerative purposes may also increase our risk of 
cancer. The risk may be especially worrying when the 
cells have accumulated numerous divisions either in 
our body or as a result of their amplification in vitro. 
The tumorigenic potential of tissue stem cells derived 
from induced pluripotent stem cells (iPSCs) [40, 41] is 
probably higher than that of tissue stem cells derived from 
embryonic stem cells. It is already known that the methods 
for inducing pluripotency may introduce carcinogenic 
DNA alterations in the cells. It is also important to realize 
that the DNA of the cells used to generate iPSCs has been 
copied more times than the DNA of embryonic stem 
cells. Embryonic stem cells divide and produce tissue 
stem cells (also referred to as adult stem cells), which 
can self-renew during our whole life. At different stages 
in life, tissue stem cells produce progenitor cells, which 
proliferate to give rise to the differentiated cells (e.g., 
fibroblasts) generally used to generate iPSCs [40]. But 
in each of these cell divisions, our DNA has been copied 
and has accumulated alterations that may lead to cancer. 
The risk of cancer associated with stem cell therapies can 
be reduced by minimizing the number of cell divisions 
required to obtain the stem cells to be introduced into 
patients.
Cancer statistics support the intimate relationship 
between tissue regeneration and cancer risk. Although 
cancer incidence increases exponentially with age, a 
deceleration is usually observed late in life [4, 42]. 
According to SEER Cancer Statistics Review 1975–
2012, the risk of being diagnosed with cancer in our 80s 
is similar or even lower than in our 70s. Importantly, an 
overall decline in tissue regenerative potential also occurs 
in later years, which is attributed to a decline in stem 
cell functionality with age [43]. This suggests that a low 
tissue regenerative potential may protect us against cancer, 
and that potentiating tissue regeneration may facilitate 
cancer development. The risk of cancer associated with 
regenerative therapies that promote the division of 
endogenous stem cells, or that employ exogenous stem 
cells, should be carefully considered in each situation. 
Knowing that the division rates of stem cells can 
be controlled and altered by numerous factors (e.g., 
mechanical, physical, chemical and neural) [44] will 
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help identify new environmental carcinogens. Future 
research might show that a variety of non-genotoxic 
chemicals generally recognized as safe can raise cancer 
risk by increasing the division rates of stem cells. Future 
research may also consistently show that regular exposure 
to electromagnetic fields (EMFs) increases cancer 
risk. Evidence has accumulated that radiofrequency 
EMFs (emitted by mobile phones and Wi-Fi routers, for 
example) increase the risk of cancer [45-47]. Recently, 
many scientists have expressed concern about the long-
term health effects associated with the ubiquitous and 
increasing exposure to EMFs generated by electric and 
wireless devices (https://emfscientist.org/). However, no 
mechanism by which EMFs could cause cancer has been 
established. Unlike ionizing radiation, EMFs are low-
energy radiations that cannot cause apparent damage to 
DNA or cells. This may prevent health organizations from 
adopting more protective measures against this rapidly 
growing form of environmental pollution worldwide. In 
my opinion, EMFs may raise cancer risk by increasing 
the division rates of stem cells [44, 48-50]. They might do 
so, for example, by disrupting the electrical interactions 
between stem cells and their niches. It is important to 
realize that the risk of cancer is not only increased by 
agents that directly or indirectly interact with the DNA, 
but also by those promoting the division of stem cells [1]. 
Promoting the division of stem cells will result in DNA 
alterations associated with cell division (e.g., mutation 
arising during DNA replication), which will occur even in 
the absence of any DNA damaging agent.
The division rates of stem cells can also be 
controlled by identifying physiological signals involved in 
the regulation of their division. This is important to reduce 
the risk of cancer associated with external factors not yet 
identified or that are difficult to control. For example, 
although we cannot prevent some types of tissue injury, 
we may control mediators (e.g., PGE2) that stimulate the 
division of stem cells following tissue injury. Controlling 
these mediators (e.g., with aspirin) may prevent the 
possible stem cell overproliferation associated with 
wound overhealing and may therefore reduce cancer risk 
[33, 35, 36]. The division rates of stem cells are probably 
influenced by a variety of cytokines, growth factors and 
hormones. Identifying and controlling these chemical 
signals may be crucial for preventing cancer. This research 
perspective has discussed that restricting the levels of the 
cytokine PGE2 by taking a daily low-dose aspirin may 
be an effective approach to reducing cancer incidence and 
mortality. Restricting the levels of the growth hormone 
(GH) and the insulin-like growth factor 1 (IGF1), the 
major mediator of the effects of GH, may also restrict the 
division rates of stem cells and may reduce cancer risk 
[51-55]. Deficiency in GH receptor and congenital IGF1 
deficiency are known to confer protection against cancer 
[51-53]. High serum concentrations of IGF1 are associated 
with an increased risk of several cancers, including breast, 
prostate, colorectal, and lung cancers [54, 55]. In addition, 
IGF1 promotes the division of normal stem cells and 
CSCs [56-61]. Controlling the levels of GH and IGF1 
may therefore be an important strategy to prevent cancer. 
Interestingly, fasting and low protein intake can reduce 
serum IGF1 levels, and can also reduce tumor growth in 
animals and cancer risk in some human populations [62, 
63]. Restriction of particular nutrients, such as essential 
amino acids, may also restrict the division rates of stem 
cells [64-66]. When the levels of particular nutrients are 
scarce, stem cells may somehow sense that it is not a good 
time for division. Identifying and restricting these nutrients 
may be an important strategy to control the division rates 
of stem cells and thus prevent cancer.
CONCLUDING REMARKS
There is a conflict between the message of this 
research perspective and that of the article by Tomasetti 
and Vogelstein [2]. I propose that the major biological 
cause of cancer is preventable, whereas they suggested that 
it is not. As mentioned before, they found a highly positive 
correlation between the number of stem cell divisions in 
a tissue and the risk of cancer in that tissue (Spearman’s 
rho = 0.81; P < 3.5 × 10−8). Pearson’s linear correlation 
0.804 was also highly significant (P < 5.15 × 10−8). They 
discussed that a linear correlation equal to 0.804 indicated 
that 65% of the differences in cancer risk among tissues 
could be explained by the number of stem cell divisions 
in those tissues. Then, they interpreted that the parameters 
“stem cell divisions” and “DNA replication mutations” 
could be interchanged, and proposed that approximately 
two-thirds (65%) of the mutations required to originate 
a cancer were random mutations arising during DNA 
replication. The other third were mutations resulting from 
hereditary or environmental factors. Since we cannot 
prevent DNA polymerases from making random mistakes 
when they replicate our DNA, they proposed that the 
major cause of cancer could not be prevented [2].
The striking differences in esophageal cancer 
incidence among countries (Table 1) are difficult to 
explain if the major biological cause of this cancer is 
random [2]. The marked reductions in esophageal cancer 
risk associated with aspirin use [8] are also difficult to 
explain if the major biological cause of this cancer is 
not preventable [2]. The raw data provided by Tomasetti 
and Vogelstein [2] show a strong association between 
the number of stem cell divisions and cancer incidence. 
This probably means that the major cause of cancer is that 
stem cells acquire DNA alterations during cell division, 
rather than that stem cells acquire random mutations 
during DNA replication. In my opinion, the parameters 
“stem cell divisions” and “DNA replication mutations” 
are not interchangeable. The main reason is that the 
mutations arising during DNA replication are random 
and unavoidable, while the division of stem cells is not 
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a random and unavoidable process. The division of stem 
cells is highly influenced by external factors (e.g., tissue 
injury) and physiological signals (e.g., PGE2). Controlling 
these factors and signals will limit the division rates of 
stem cells; this will restrict the acquisition of DNA 
alterations during cell division, including those arising 
during DNA replication.
As discussed by Tomasetti and Vogelstein, our 
stem cells will acquire DNA alterations no matter what 
we do. Stem cells have to divide, and some errors arising 
during cell division are unavoidable. Cancer prevention 
will partially protect stem cells from getting damaged and 
will lead to a cancer-free life in many cases; this partial 
protection may be sufficient to avoid in many cases 
“the straw that breaks the camel’s back”. In other cases, 
primary prevention efforts will not stop some stem cells 
from becoming malignant. But prevention is still possible 
in these cases. The accumulation of DNA alterations 
in stem cells can make them vulnerable to specific 
pharmacological and non-pharmacological interventions. 
Finding a chemopreventive drug to selectively kill mutated 
stem cells before they give rise to cancer is possible. 
Mutated stem cells may also be eliminated by selective 
restriction of specific amino acids [67]. In my opinion, 
all cancer cases are potentially preventable. Future 
research will hopefully show the way to achieve it. In 
the meantime, controlling the division rates of stem cells 
may be an essential strategy to prevent cancer. This can 
be accomplished by identifying and controlling external 
factors that promote the division of stem cells, and by 
identifying and controlling internal signals that regulate 
their division rates.
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